Special Issue "Proteomics-Based Development of Biomarkers in Global Chronic Disease"

A special issue of Proteomes (ISSN 2227-7382).

Deadline for manuscript submissions: closed (15 December 2018)

Special Issue Editor

Guest Editor
Dr. Ian James Martins

Centre of Excellence in Alzheimer’s Disease Research and Care, School of Medical Sciences, Edith Cowan University, Joondalup, Australia
Website | E-Mail
Interests: Alzheimer's Disease; appetite regulation; environment; nutrition; senescence; accelerated disease; metabolism; type 3 diabetes; heat shock gene; mitochondrial biogenesis; autoimmune disease

Special Issue Information

Dear Colleagues,

Early diagnosis of global organ disease involves genomic, lipidomic and proteomic biomarker tests that may diagnose early neuron dysfunction with the prevention of various organ diseases. Diet and nutrition are closely linked to accelerated aging and may allow biomarker tests to provide adequate information with relevance to the immune system dysfunction and the severity of chronic diseases. In spite of various biomarker tests and analyte measurements for chronic diseases such as obesity and diabetes abnormal nuclear–mitochondria interactions persist with inflammation involved in the induction of programmed cell death. For example, in the developing world, LPS and xenobiotic levels may be responsible for altered biological interactions and supersede diagnostic technologies for biomarker analysis. Diagnostic technologies for biomarker analysis have become important with projected costs for biomarker analysis expected to increase to billions of dollars in the next few years but altered biological and cell membrane interactions may not allow early diagnosis of immune system dysfunction related to early progression of global organ disease.

Dr. Ian James Martins
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Proteomes is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 550 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • Global health
  • Chronic disease
  • Technologies
  • Lipidomics
  • Diagnosis
  • Proteomics
  • Genomics
  • Biomarker tests
  • Diabetes

Published Papers

There is no accepted submissions to this special issue at this moment.
Proteomes EISSN 2227-7382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top